These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10931241)

  • 21. Altered expression of CD44 in human prostate cancer during progression.
    Nagabhushan M; Pretlow TG; Guo YJ; Amini SB; Pretlow TP; Sy MS
    Am J Clin Pathol; 1996 Nov; 106(5):647-51. PubMed ID: 8929476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy.
    Aaltomaa S; Lipponen P; Viitanen J; Kankkunen JP; Ala-Opas M; Kosma VM
    Eur Urol; 2000 Nov; 38(5):555-62. PubMed ID: 11096236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 variant exon epitopes in primary breast cancer and length of survival.
    Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
    Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer.
    Aaltomaa S; Lipponen P; Ala-Opas M; Kosma VM
    Eur Urol; 2001 Feb; 39(2):138-44. PubMed ID: 11223672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma.
    Takanami I; Takeuchi K; Naruke M
    Oncol Rep; 2000; 7(5):1065-7. PubMed ID: 10948339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
    Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
    Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Anti-CD44 Variant 3 Monoclonal Antibody C
    Suzuki H; Kitamura K; Goto N; Ishikawa K; Ouchida T; Tanaka T; Kaneko MK; Kato Y
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
    Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
    Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
    Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
    Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD44 isoforms and beta 1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential.
    Seelentag WK; Böni R; Günthert U; Futo E; Burg G; Heitz PU; Roth J
    J Cutan Pathol; 1997 Apr; 24(4):206-11. PubMed ID: 9138110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of CD44 isoform expression in endometrial cancer.
    Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C
    Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
    Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
    Godge PY; Poonja LS
    Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse.
    Beham-Schmid C; Heider KH; Hoefler G; Zatloukal K
    J Pathol; 1998 Dec; 186(4):383-9. PubMed ID: 10209487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
    Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
    Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD44 variant proteins in adenocarcinoma of Barrett's esophagus and its relation to prognosis.
    Böttger TC; Youssef V; Dutkowski P; Maschek H; Brenner W; Junginger T
    Cancer; 1998 Sep; 83(6):1074-80. PubMed ID: 9740070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma.
    Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH
    Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications.
    Berner HS; Davidson B; Berner A; Risberg B; Kristensen GB; Trope CG; Van de Putte G; Nesland JM
    Clin Exp Metastasis; 2000; 18(2):197-202. PubMed ID: 11235996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study.
    Matuschek C; Lehnhardt M; Gerber PA; Poremba C; Hamilton J; Lammering G; Orth K; Budach W; Bojar H; Bölke E; Peiper M
    Eur J Med Res; 2014 Feb; 19(1):6. PubMed ID: 24491153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival.
    Endo K; Terada T
    J Hepatol; 2000 Jan; 32(1):78-84. PubMed ID: 10673070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.